http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013162047-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2534bb9f13460c6429c25acf8df25d0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2d570d3bbe45d71814c789fb64fd421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98f68c23614d57791ccc3fad3db4606a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d47bd5a78ae397aeb7d1c9d385e1f3f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78f2216558c0512d6c997b56a3d343af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e51098886626a8962b3bb5810122169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f35d293120156c88f700ff4598410c6e
publicationDate 2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013162047-A1
titleOfInvention Therapeutic agent for secondary hyperparathyroidism
abstract The present invention provides a therapeutic agent for secondary hyperparathyroidism which comprises as an active component a vitamin D 3 derivative represented by formula (1) or a medically acceptable solvate thereof.
priorityDate 2012-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0162723-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009256361-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9952863-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9903829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006019169-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012057068-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468139711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468139710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468139705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID325126843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID324141361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87058084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67499904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID323077089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12303103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406008
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228779248

Total number of triples: 43.